Morning program :
9 a.m.: Opening speeches
Wei WANG, lecturer at the University of Political Science and Law of China (UPCL)
Bénédicte BEVIERE-BOYER, lecturer-HDR at the University of Paris 8, Center for Legal Research of Paris 8
Human “ameliorative” medicine: authorized, limited or prohibited?
Chair: Bernard BAERTSCHI, member of the Ethics Committee of INSERM and Li ZHANG, professor at the University of Political Science and Law University of China (UPCL)
• 09:45 am: Presentation of the general theme by the chairmen of the session
• 10:15 am: Transhumanism and the protection of the right to health: conflict or coordination?
Wei WANG, Associate Professor at the University of Political Science and Law of China (UPCL)
• 10:30 am: The legal regime in Taiwan regarding ameliorative medicine,
Yaoming HSU, Professor at Taiwan Political University
• 10:45 am: Transhumanism and the development of health protection laws in China, Hualin SONG
• 11:00 am.: The legal feasibility of the promise of augmented humans in France, Lina WILLIATTE, professor of private law at the Catholic University of Lille.
• 11:15 am: Telemedicine from the Perspective of Transhumanism: Policy, Law and Ethics, Xuanlin LIU
• 11:30 am: The law on biosafety and the development of new biomedical technologies in the context of transhumanism, Peng ZHAO, Professor of the Institute of Law-Based Government at the University of Political Science and Law of China (UPCL)
• 11:45 am: Regulatory issues for research and development of innovative medical devices that can improve human functions
Yang YUE, Professor of the Institute of Pharmacy at Tsinghua University (SPS)
• 12:00 am: The role of the government in ameliorative medicine: regulator or provider?
Li ZHANG, Associate Professor at the University of Political Science and Law of China (UPCL), vice-dean of the Faculty of Law
• 12:15 am: Discussion and break
The Challenge of Preserving Humanity in the Face of the Development of
to the development of ameliorative medicine
Chair: Émilie GAILLARD, Associate Professor in private law at Sciences po. Rennes and general coordinator of the Normandy Chair for Peace
and Li XIAOYONG, Director of the Health Law Research Center, Associate Professor at the Medical University (UMC)
Afternoon program :
• 2 pm: Presentation of the general theme by the chairmen of the session • 2.30 pm: Will the spirit of Asilomar 1975 resist the conquest of the stars, Paul JORION, anthropologist, sociologist and psychoanalyst, associate professor at the Catholic University of Lille • 2.45 pm : The protection of the human condition via the concept of ethics by the top, Loïc ETIENNE, emergency doctor, specialist in e-health • 3 pm : Fundamental rights as the frontiers of human enhancement medicine, Aurélie MAHALATCHIMY, CNRS research fellow in sociology and legal sciences, and Guylène NICOLAS, Associate Professor HDR in public law at the University of Aix-Marseille. • 3.15 pm : Preventive medicine or the search for a protected man, Amélie DIONISI-PEYRUSSE, Associate Professor in private law at the University of Rouen Normandie. • 3.30 pm: From ameliorative medicine to body ownership: towards a body capitalism? Amandine CAYOL, Associate Professor in private law at the University of Caen Normandie • 3.45 pm : The creation of an augmented soldier: opportunities and risks of ameliorative medicine “, Aloïse QUESNE, Associate Professor in private law at the University of Paris-Saclay, Evry Val d’Essonne. • 4:00 p.m.: Genome editing as an improvement of humanity, Xavier BIOY, professor of public law at the University of Toulouse 1 Capitole. • 4:15 pm – Debates 5PM : SUMMARY REPORT Noël-Jean MAZEN, Associate Professor emeritus at the University of Burgundy WANG QING BIN, Professor of the Institute of Law-based Government at the University of Political Science and Law of China (UPCL)
Round table n°3 – Is “human ameliorative” medicine authorized, limited or prohibited?
Chair: Bernard BAERTSCHI, member of the INSERM Ethics Committee and Li ZHANG,Professor at the University of Political Science and Chinese law (UPCL).